Immunai Company
Immunai is a biotech company that combines single cell genomics with ML algorithms to enable high resolution profiling of the immune system.
Investors
Funding Status:
Early Stage Venture
Headquarters:
New York, New York, United States
Acquisitions Number:
2
Founded Date:
2018-12-01
Employee Number:
101-250
Last Funding Type:
Series B
Total Funding:
295000000.0
Industry:
Medical BioTech
Investors Number:
13.0
Technology:
Artificial Intelligence, Biotechnology, Machine Learning, Therapeutics
Investor Type:
info@immunai.com
Last Funding Date:
2021-10-27